Arterial Events in Patients With Chronic Myeloid Leukemia Receiving Treatment With Second Generation Tyrosine Kinase Inhibitors
Klinicheskaya Onkogematologiya/Clinical Oncohematology - Russian Federation
doi 10.21320/2500-2139-2016-9-4-474-484
Full Text
Open PDFAbstract
Available in full text
Date
December 13, 2016
Authors
Publisher
Practical Medicine Publishing House